TrialCommunications biology2025

Pharmacological and pupillary evidence for the noradrenergic contribution to reinforcement learning in Parkinson's disease.

Claire O'Callaghan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.